劲拓股份 reported revenue of ¥0.42B for the period ended 2026-06-30, +13.3% year on year. Net income was ¥0.06B, a 13.7% net margin on a 36.1% gross margin. The largest revenue line is 电子装联设备 at 94% of the total. Free cash flow for the period was ¥0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.42B | +13.3% |
| Gross profit | ¥0.15B | — |
| Operating income | ¥0.06B | — |
| Net income | ¥0.06B | +7.7% |
| Gross margin | 36.1% | Net margin 13.7% |
| Revenue Q/Q | +47.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 电子装联设备 | ¥0.39B | 93.7% |
| 其他(补充) | ¥0.02B | 5.8% |
| 光电显示设备 | ¥0.00B | 0.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.27B | 63.9% |
| R&D | ¥0.02B | 5.1% |
| SG&A | ¥0.06B | 15.4% |
| Tax & other | ¥0.01B | 1.6% |
| Item | Amount |
|---|---|
| Total assets | ¥1.17B |
| Total liabilities | ¥0.43B |
| Shareholders' equity | ¥0.74B |
| Equity / assets | 62.9% |
| Operating cash flow | ¥0.03B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥0.02B |
| Cash conversion (OCF / net income) | 67% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
花园生物 ・ 宝色股份 ・ 汉宇集团 ・ 博济医药 ・ 科隆股份 ・ 九强生物 ・ 凯发电气 ・ 道氏技术 ・ 正业科技 ・ 金盾股份 ・ 迦南科技 ・ 中光防雷
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies